Latvia-based pharmaceutical company Solé Pharma has expanded its operations into the Philippines, responding to growing consumer demand for high-quality health supplements. The company’s product line is now available through major retailers and e-commerce platforms in the country.
The entry comes as the Philippines’ supplement market is projected to grow at a compound annual growth rate of 9.32% from 2024 to 2029, driven by increasing awareness of preventive healthcare and interest in wellness. Sole Pharma aims to tap into this expanding market with its range of science-based formulations that target key areas such as cognitive function, stress management, joint health, and liver care.
Sole Pharma was established in 2008 and currently exports to more than 25 countries. Its products are manufactured in Europe and comply with Good Manufacturing Practices (GMP), US and Philippine FDA standards, and ISO regulations.
In the Philippines, Sole Pharma is introducing a range of supplements targeted at specific consumer segments. These include cognitive function supplements for students and working professionals, stress management products for individuals with high-stress lifestyles, and eye health supplements for those experiencing prolonged screen exposure. The company also offers joint support supplements intended for older adults and individuals with physically demanding routines, and liver health products geared toward consumers seeking preventive care and detoxification support.
(Source: The Manila Times)
